PCV (Pneumococcal Conjugate Vaccine) bulk supplier for pharma manufacturers

Pcv (Pneumococcal Conjugate Vaccine) 0.5 mL Suppliers & Bulk Manufacturers

Available Forms: Vial doses, Pre-filled syringes

Available Strengths: 0.5 mL

Reference Brands: Prevnar 13(US)

Category: Vaccines

PCV (Pneumococcal Conjugate Vaccine) stimulates immunity by introducing polysaccharides linked to proteins, prompting the body to produce antibodies against pneumococcal bacteria. It prevents pneumonia, meningitis, and bacteremia, reducing illness, hospitalizations, and death, especially in children, supporting lifelong protection and community health.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

PCV (Pneumococcal Conjugate Vaccine) is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval requires comprehensive clinical data; in the EU, CE marking certifies conformity with in vitro diagnostic and medicinal regulations. These vaccines undergo validation, stability testing, and extensive audits, with detailed documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective pneumococcal vaccines for global immunization efforts reducing pneumonia, meningitis, and sepsis.

Pcv (Pneumococcal Conjugate Vaccine) — third party manufacturing & bulk supply

Pcv (Pneumococcal Conjugate Vaccine) 0.5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Pcv (Pneumococcal Conjugate Vaccine) is supplied as Vial doses, Pre-filled syringes — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pcv (Pneumococcal Conjugate Vaccine) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Pcv (Pneumococcal Conjugate Vaccine) →

Back to Listing

Frequently Asked Questions

Pneumococcal Conjugate Vaccine (PCV) is used to protect against infections caused by the bacterium Streptococcus pneumoniae. It helps prevent serious diseases such as pneumonia, meningitis, and bacteremia, especially in infants, young children, the elderly, and individuals with weakened immune systems.

PCV is made from purified capsular polysaccharides of different serotypes of Streptococcus pneumoniae, which are chemically linked (conjugated) to a carrier protein, typically a non-toxic diphtheria CRM197 protein. This conjugation enhances the immune response, especially in young children.

The trade names for PCV include Prevnar 13, Vaxneuvance, and Synflorix.

Prevnar 13 is manufactured by Pfizer Inc., Vaxneuvance is made by Merck & Co., and Synflorix is produced by GlaxoSmithKline (GSK).

The generic name of this product is Pneumococcal Conjugate Vaccine.

The brand names of this vaccine are Prevnar 13, Vaxneuvance, and Synflorix.

Pneumococcal Conjugate Vaccine is manufactured in various locations globally depending on the brand. Pfizer manufactures Prevnar 13 in the United States and Belgium, Merck produces Vaxneuvance in the United States, and GSK manufactures Synflorix in Belgium.